{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:08:50Z","timestamp":1781276930209,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijrobp.2020.02.020","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T21:54:54Z","timestamp":1582062894000},"page":"353-359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer"],"prefix":"10.1016","volume":"107","author":[{"given":"Shir","family":"Schlosser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Shatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Galper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilanit","family":"Shahadi-Dromi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Finkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Rasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Laitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Evron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Sklair-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav A.","family":"Ben-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.02.020_bib1","first-page":"66","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Sci New Ser"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ng1295-428","article-title":"Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype\u2013phenotype correlation","volume":"11","author":"Gayther","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cncr.29041","article-title":"Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian","volume":"121","author":"Mersch","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib4","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women","volume":"16","author":"Robson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10\u2008801 women in 17 randomised trials","volume":"378","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.breast.2017.07.004","article-title":"Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results","volume":"35","author":"Burt","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib10","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.bjc.6605435","article-title":"Second solid cancers after radiotherapy for breast cancer in SEER cancer registries","volume":"102","author":"Berrington de Gonzalez","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010593","article-title":"Second malignancy in young early-stage breast cancer patients with modern radiotherapy: A long-term population-based study (A STROBE-compliant study)","volume":"97","author":"Xie","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2013.01.002","article-title":"Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG)","volume":"106","author":"Grantzau","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jtho.2017.01.021","article-title":"Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: A nationwide population-based cohort analysis","volume":"12","author":"Huang","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.radonc.2014.05.004","article-title":"Risk of second primary lung cancer in women after radiotherapy for breast cancer","volume":"111","author":"Grantzau","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2014.10.004","article-title":"Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients","volume":"114","author":"Grantzau","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/aje\/kwi050","article-title":"Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer","volume":"161","author":"Zablotska","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijrobp.2006.01.017","article-title":"Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer","volume":"65","author":"Salminen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clon.2013.06.007","article-title":"Biological consequences of radiation-induced DNA damage: Relevance to radiotherapy","volume":"25","author":"Lomax","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/10715762.2011.653969","article-title":"Mechanisms of free radical-induced damage to DNA","volume":"46","author":"Dizdaroglu","year":"2012","journal-title":"Free Radic Res"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib20","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1038\/sj.onc.1203165","article-title":"Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2","volume":"18","author":"Foray","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijrobp.2009.10.020","article-title":"Increased chromosomal radiosensitivity in women carrying BRCA1\/BRCA2 mutations assessed with the G2 assay","volume":"76","author":"Ernestos","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijrobp.2015.05.037","article-title":"BRCA1 mutation: A predictive marker for radiation therapy?","volume":"93","author":"Kan","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semradonc.2010.08.008","article-title":"Radiotherapy in the treatment of hereditary breast cancer","volume":"21","author":"Pierce","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-010-0894-z","article-title":"Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: Comparison of breast conservation and mastectomy","volume":"121","author":"Pierce","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib25","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2000.18.19.3360","article-title":"Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1\/2 mutations","volume":"18","author":"Pierce","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-013-2621-z","article-title":"Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations","volume":"140","author":"Kadouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/annonc\/mdy515","article-title":"Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer","volume":"30","author":"Evron","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1667\/RR3525.1","article-title":"Reconstruction for therapeutic and diagnostic dose radiation exposures: Use in epidemiological studies","volume":"166","author":"Stovall","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W","article-title":"Sarcoma arising in irradiated bone: Report of eleven cases. 1948","volume":"82","author":"Cahan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","article-title":"Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients","volume":"121","author":"Grantzau","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-8140(01)00468-6","article-title":"Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer","volume":"62","author":"Muren","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1748-717X-3-6","article-title":"Dosimetric consequences of the shift towards computed tomography guided target definition and planning for breast conserving radiotherapy","volume":"3","author":"van der Laan","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199801293380506","article-title":"Papillary and follicular thyroid carcinoma","volume":"338","author":"Schlumberger","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2307\/3579003","article-title":"Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies","volume":"141","author":"Ron","year":"1995","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00411-002-0163-6","article-title":"Thyroid cancer incidence among liquidators of the Chernobyl accident","volume":"41","author":"Ivanov","year":"2002","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib37","doi-asserted-by":"crossref","first-page":"101664","DOI":"10.1016\/j.canep.2019.101664","article-title":"Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015","volume":"64","author":"Schonfeld","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib39","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib40","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian","volume":"7","author":"Friedenson","year":"2005","journal-title":"MedGenMed"},{"key":"10.1016\/j.ijrobp.2020.02.020_bib41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1006489918700","article-title":"Increased risk of second cancers following breast cancer: Role of the initial treatment","volume":"61","author":"Rubino","year":"2000","journal-title":"Breast Cancer Res Treat"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620302194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620302194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:47:18Z","timestamp":1759744038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620302194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0360301620302194"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.020","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}